Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. (Q54628324)

1 June 2018

title

Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. (English)

1 reference

1 June 2018

author name string

J S Thompson

1

1 reference

1 June 2018

Y Chu

2

1 reference

1 June 2018

J F Glass

3

1 reference

1 June 2018

S A Brown

4

1 reference

1 June 2018

language of work or name

English

0 references

publication date

31 August 2009

1 reference

1 June 2018

Bone Marrow Transplantation

published in

1 reference

1 June 2018

volume

45

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

712-722

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2009.215

exact match

0 references

cites work

Pathophysiology of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

The role of interleukin-12 and interferon-gamma in GVHD and GVL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

The interleukin-12 family: new players in transplantation immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

IL-23: changing the verdict on IL-12 function in inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

The IL-12 family of cytokines in infection, inflammation and autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-17: a mediator of inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

The IL-23/IL-17 axis in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

IL-17 contributes to CD4-mediated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Interleukin-22 Deficiency Accelerates the Rejection of Full Major Histocompatibility Complex-Disparate Heart Allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host disease mortality after major H2 incompatible transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Interleukin-17 antagonism inhibits acute but not chronic vascular rejection

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.215

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.215

1 reference

1 June 2018

1 reference

1 June 2018